{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:48:48Z","timestamp":1761630528103},"reference-count":39,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2191,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1111\/j.1529-8019.2009.01257.x","type":"journal-article","created":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T17:51:23Z","timestamp":1251827483000},"page":"407-417","source":"Crossref","is-referenced-by-count":8,"title":["Controversies in the management of the cutaneous T cell lymphomas"],"prefix":"10.1155","volume":"22","author":[{"given":"John A.","family":"Zic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"issue":"10","key":"10.1111\/j.1529-8019.2009.01257.x-BIB1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01257.x-BIB2","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1111\/j.1529-8019.2009.01257.x-BIB3","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002","volume":"143","author":"Criscione","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2009.01257.x-BIB4","doi-asserted-by":"crossref","unstructured":"4.\u2002 Bradford PT , Devesa SS , Anderson WF , et\u2003al. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3,884 cases. Blood March 11, 2009: epub.","DOI":"10.1158\/1940-6207.PREV-08-A81"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01257.x-BIB5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.pas.0000153121.57515.c6","article-title":"Histopathologic features of early (patch) lesions of mycosis fungoides: a morphologic study on 745 biopsy specimens from 427 patients","volume":"29","author":"Massone","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01257.x-BIB6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1396-0296.2003.01637.x","article-title":"Diagnosis, staging, and monitoring of cutaneous T-cell lymphoma","volume":"16","author":"Wood","year":"2003","journal-title":"Dermatol Ther"},{"issue":"7","key":"10.1111\/j.1529-8019.2009.01257.x-BIB7","first-page":"951","article-title":"The applicability of T-cell receptor gamma gene rearrangement as an adjuvant diagnostic tool in skin biopsies for cutaneous T-cell lymphoma","volume":"27","author":"Khalil","year":"2006","journal-title":"Saudi Med J"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01257.x-BIB8","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/sj.jid.5701109","article-title":"TCRgamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples","volume":"128","author":"Ponti","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01257.x-BIB9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","article-title":"Defining early mycosis fungoides","volume":"53","author":"Pimpinelli","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01257.x-BIB10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1600-0560.2007.00858.x","article-title":"Regarding the algorithm for the diagnosis of early mycosis fungoides proposed by the International Society for Cutaneous Lymphomas: suggestions from routine histopathology practice","volume":"35","author":"Ferrara","year":"2008","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01257.x-BIB11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0022-3999(02)00396-3","article-title":"Predicting psychological distress in patients with leukaemia and lymphoma","volume":"54","author":"Montgomery","year":"2003","journal-title":"J Psychosomatic Res"},{"issue":"11","key":"10.1111\/j.1529-8019.2009.01257.x-BIB12","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/archderm.1996.03890350051009","article-title":"Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis","volume":"132","author":"Kim","year":"1996","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1111\/j.1529-8019.2009.01257.x-BIB13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01257.x-BIB14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1396-0296.2003.01639.x","article-title":"Treatment of patch-stage mycosis fungoides with topical corticosteroids","volume":"16","author":"Zackheim","year":"2003","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01257.x-BIB15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2340\/00015555-0283","article-title":"Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study","volume":"87","author":"Ahmad","year":"2007","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01257.x-BIB16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0781.2005.00183.x","article-title":"Narrow band UVB (311\u2003nm), psoralen UVB (311\u2003nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right-left comparative study","volume":"21","author":"El-Mofty","year":"2005","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01257.x-BIB17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1468-3083.2006.01557.x","article-title":"UVB in the management of early stage mycosis fungoides","volume":"20","author":"Pavlotsky","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01257.x-BIB18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0190-9622(93)70155-M","article-title":"Home UV phototherapy of early mycosis fungoides: long-term follow-up observations in thirty-one patients","volume":"29","author":"Resnik","year":"1993","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01257.x-BIB19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archderm.139.2.165","article-title":"Topical nitrogen mustard in the management of mycosis fungoides: update of the stanford experience","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1111\/j.1529-8019.2009.01257.x-BIB20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1444-0903.2004.00424.x","article-title":"Audit of consultant physicians' reply letters for referrals to clinics in a tertiary teaching hospital","volume":"34","author":"Scott","year":"2004","journal-title":"Internal Med J"},{"issue":"26","key":"10.1111\/j.1529-8019.2009.01257.x-BIB21","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJM198912283212603","article-title":"A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides [see comments","volume":"321","author":"Kaye","year":"1989","journal-title":"N Eng J Med"},{"issue":"3","key":"10.1111\/j.1529-8019.2009.01257.x-BIB22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archderm.138.3.325","article-title":"Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma","volume":"138","author":"Breneman","year":"2002","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01257.x-BIB23","first-page":"581","article-title":"Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma","volume":"137","author":"Duvic","year":"2001","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01257.x-BIB24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2133.2006.07329.x","article-title":"Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion","volume":"155","author":"Assaf","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2009.01257.x-BIB25","doi-asserted-by":"crossref","unstructured":"25.\u2002 Abbott RA , Whittaker SJ , Morris SL , et\u2003al. Bexarotene therapy for mycosis fungoides and Sezary syndrome. Br J Dermatol February 12, 2009: epub.","DOI":"10.1111\/j.1365-2133.2009.09037.x"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01257.x-BIB26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2141.2009.07596.x","article-title":"Hypertriglyceridaemia with bexarotene in cutaneous T cell lymphoma: the role of omega-3 fatty acids","volume":"145","author":"Musolino","year":"2009","journal-title":"Br J Haematol"},{"issue":"1221","key":"10.1111\/j.1529-8019.2009.01257.x-BIB27","first-page":"91","volume":"47","author":"Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia","year":"2005","journal-title":"Med Lett Drugs Ther"},{"issue":"3","key":"10.1111\/j.1529-8019.2009.01257.x-BIB28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/art.22432","article-title":"Novel action of n-3 polyunsaturated fatty acids: inhibition of arachidonic acid-induced increase in tumor necrosis factor receptor expression on neutrophils and a role for proteases","volume":"56","author":"Moghaddami","year":"2007","journal-title":"Arthritis and rheumatism"},{"issue":"10","key":"10.1111\/j.1529-8019.2009.01257.x-BIB29","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1358\/dnp.2008.21.10.1314058","article-title":"Fatty acid facts, part III: Cardiovascular disease, or, a fish diet is noy fishy","volume":"21","author":"Pauwels","year":"2008","journal-title":"Drug news & perspectives"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01257.x-BIB30","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0889-8588(03)00109-6","article-title":"Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2","volume":"17","author":"Rook","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01257.x-BIB31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bcp.2007.04.007","article-title":"HDAC inhibitors: Clinical update and mechanism-based potential","volume":"74","author":"Glaser","year":"2007","journal-title":"Biochem pharmacol"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01257.x-BIB32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood-2006-06-025999","article-title":"Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)","volume":"109","author":"Duvic","year":"2007","journal-title":"Blood"},{"issue":"21","key":"10.1111\/j.1529-8019.2009.01257.x-BIB33","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2006.10.2434","article-title":"Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma","volume":"25","author":"Olsen","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01257.x-BIB34","first-page":"33","article-title":"Systemic monotherapy vs combination therapy for CTCL: rationale and future strategies","volume":"21","author":"Duvic","year":"2007","journal-title":"Oncol (Williston Park)"},{"issue":"9","key":"10.1111\/j.1529-8019.2009.01257.x-BIB35","first-page":"1985","article-title":"Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the S\u00e9zary syndrome)","volume":"85","author":"Jones","year":"1999","journal-title":"Cancer"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01257.x-BIB36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1396-0296.2003.01646.x","article-title":"The treatment of cutaneous T-cell lymphoma with photopheresis","volume":"16","author":"Zic","year":"2003","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01257.x-BIB37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-2133.2000.03286.x","article-title":"Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies","volume":"142","author":"Russell-Jones","year":"2000","journal-title":"Br J Dermatol"},{"issue":"25","key":"10.1111\/j.1529-8019.2009.01257.x-BIB38","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1200\/JCO.2005.02.774","article-title":"Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides","volume":"23","author":"Molina","year":"2005","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1111\/j.1529-8019.2009.01257.x-BIB39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.bmt.1703872","article-title":"Treatment of advanced mycosis fungoides by allogeneic stem-cell transplantation with a nonmyeloablative regimen","volume":"31","author":"Soligo","year":"2003","journal-title":"Bone Marrow Transplant"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2009.01257.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2009.01257.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T15:18:51Z","timestamp":1685114331000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2009.01257.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2009.01257.x","relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}